These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32892693)
1. Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34. Janji B; Hasmim M; Parpal S; De Milito A; Berchem G; Noman MZ Autophagy; 2020 Nov; 16(11):2110-2111. PubMed ID: 32892693 [TBL] [Abstract][Full Text] [Related]
2. Firing up the cold tumors by targeting Vps34. Janji B; Hasmim M; Parpal S; Berchem G; Noman MZ Oncoimmunology; 2020 Aug; 9(1):1809936. PubMed ID: 32939326 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy. Noman MZ; Parpal S; Van Moer K; Xiao M; Yu Y; Viklund J; De Milito A; Hasmim M; Andersson M; Amaravadi RK; Martinsson J; Berchem G; Janji B Sci Adv; 2020 May; 6(18):eaax7881. PubMed ID: 32494661 [TBL] [Abstract][Full Text] [Related]
4. Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34. Bartolini E; Van Moer K; Janji B Oncoimmunology; 2024; 13(1):2364958. PubMed ID: 38872753 [TBL] [Abstract][Full Text] [Related]
5. Autophagy-related protein PIK3C3/VPS34 controls T cell metabolism and function. Yang G; Song W; Postoak JL; Chen J; Martinez J; Zhang J; Wu L; Van Kaer L Autophagy; 2021 May; 17(5):1193-1204. PubMed ID: 32268825 [TBL] [Abstract][Full Text] [Related]
6. A Novel Tri-Functional Liposome Re-Educates "Cold Tumor" and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD-L1 Blockade. Zhou F; Li X; Xue X; Li S; Fan G; Cai Y; Chang Z; Qu J; Liu R Adv Healthc Mater; 2023 Apr; 12(11):e2202757. PubMed ID: 36652763 [TBL] [Abstract][Full Text] [Related]
7. PIK3C3/VPS34 control by acetylation. Su H; Liu W Autophagy; 2018; 14(6):1086-1087. PubMed ID: 28980854 [TBL] [Abstract][Full Text] [Related]
8. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041 [TBL] [Abstract][Full Text] [Related]
9. An alcoholic extract of Thuja orientalis L. leaves inhibits autophagy by specifically targeting pro-autophagy PIK3C3/VPS34 complex. Jung J; Chun Y; Jang YP; Oh MS; Kim JH; Kim J Sci Rep; 2021 Sep; 11(1):17712. PubMed ID: 34489486 [TBL] [Abstract][Full Text] [Related]
10. Development of in vitro PIK3C3/VPS34 complex protein assay for autophagy-specific inhibitor screening. Kim TM; Baek JH; Kim JH; Oh MS; Kim J Anal Biochem; 2015 Jul; 480():21-7. PubMed ID: 25862085 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework. Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343 [TBL] [Abstract][Full Text] [Related]
13. 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation. Qu QX; Zhu XY; Du WW; Wang HB; Shen Y; Zhu YB; Chen C Front Immunol; 2020; 11():577. PubMed ID: 32391001 [TBL] [Abstract][Full Text] [Related]
14. Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy. Benoit A; Vogin G; Duhem C; Berchem G; Janji B Cells; 2023 Jul; 12(13):. PubMed ID: 37443821 [TBL] [Abstract][Full Text] [Related]
16. Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy. Lequeux A; Noman MZ; Xiao M; Van Moer K; Hasmim M; Benoit A; Bosseler M; Viry E; Arakelian T; Berchem G; Chouaib S; Janji B Oncogene; 2021 Jul; 40(28):4725-4735. PubMed ID: 34155342 [TBL] [Abstract][Full Text] [Related]
17. Tumor cell-intrinsic CD274/PD-L1: A novel metabolic balancing act with clinical potential. Clark CA; Gupta HB; Curiel TJ Autophagy; 2017 May; 13(5):987-988. PubMed ID: 28368722 [TBL] [Abstract][Full Text] [Related]
18. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α Parekh VV; Pabbisetty SK; Wu L; Sebzda E; Martinez J; Zhang J; Van Kaer L Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6371-E6380. PubMed ID: 28716903 [TBL] [Abstract][Full Text] [Related]
19. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics. Han X; Li H; Zhou D; Chen Z; Gu Z Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988 [TBL] [Abstract][Full Text] [Related]
20. The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer. Chu CA; Wang YW; Chen YL; Chen HW; Chuang JJ; Chang HY; Ho CL; Chang C; Chow NH; Lee CT Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]